查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1848567

胃食道逆流症治療設備市場（依產品類型、最終用戶和通路分類）－2025-2032年全球預測

Gastroesophageal Reflux Disease Devices Market by Product Type, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胃食道逆流治療設備市場規模將達 190.4 億美元，複合年成長率為 14.05%。

關鍵市場統計數據
基準年 2024 66.5億美元
預計年份：2025年 75.8億美元
預測年份 2032 190.4億美元
複合年成長率 (%) 14.05%

全面審視不斷發展的胃食道逆流症（GERD）器材領域，以及推動快速創新的臨床和商業性因素。

胃食道逆流症仍然是一種具有重要臨床意義的疾病，它持續推動內視鏡、磁振造影、射頻和外科手術等治療方法的創新和器械研發。臨床醫生和醫療系統日益尋求能夠減少長期藥物依賴、最大限度降低手術全期風險並實現當日治療的治療方法。因此，醫療設備領域呈現出快速迭代、更加重視以病人為中心的治療效果以及門診病人最佳化技術的湧現等特點。

同時，支付方的審查和醫院的採購週期正在影響醫療器材的普及速度，對安全性和耐用性的臨床證據要求也日益嚴格。從住院治療轉向門診手術中心和專科診所，迫使醫療器材製造商提供緊湊、經濟高效且可互通的系統，以便與現有的手術室技術體系整合。因此，商業和臨床領導者必須應對這樣的環境：技術前景必須與可重複的臨床表現和可行的報銷策略相符。

深入分析影響胃食道逆流（GERD）器材應用和醫療服務提供者決策的臨床、技術和商業性變革

胃食道逆流治療器械領域正經歷一場變革，其驅動力主要來自手術方式的改變，包括微創手術平台的興起、磁性括約肌加固理念的成熟以及經口和內鏡縫合技術的改進。臨床醫生正致力於在控制症狀和保留解剖結構之間尋求平衡，而器械研發人員則不斷迭代改進，優先考慮器械的易用性、可重複性和降低術後併發症發生率。

此外，隨著機器人輔助和增強成像技術的出現，外科胃底折疊術也在不斷發展；射​​頻消融系統則透過導管設計和能量傳輸精度的提升而脫穎而出。這些技術進步與醫療保健系統的發展趨勢同步進行，例如門診服務的擴展、基於價值的合約模式以及對健康經濟學的關注。因此，市場參與企業被迫將臨床證據的產生與使用者培訓計畫結合，並重新設計其商業模式，以支持包括獨立門診中心、醫院附屬機構和專科診所在內的各類終端使用者。因此，那些能夠將工程敏捷性與強大的臨床檢驗和適應性市場策略相結合的機構，將在這一變革時期過程中佔據優勢。

對 2025 年生效的美國累積關稅將如何重塑供應鏈、採購行為和醫療設備商業化策略進行策略分析。

自2025年起生效的美國新關稅的累積效應正在重塑整個胃食道逆流症醫療器材生態系統的供應鏈策略、零件採購決策和定價動態。依賴進口特種零件（例如精密導管、磁性材料和微電子元件）的醫療器材製造商正面臨更高的到岸成本，這促使他們重新評估材料成本最佳化策略，並加快對國內或近岸供應商的評估。因此，採購團隊正在優先考慮雙重採購、簽訂長期供應商合約以及增加庫存緩衝，以降低成本波動和前置作業時間不確定性。

此外，關稅主導的成本壓力正在影響市場競爭策略。有些製造商選擇自行承擔成本上漲以維持價格競爭力，而有些製造商則推出差異化的服務組合以保障利潤。醫院和門診手術中心正在透過加強資本配置審查並要求醫療設備供應商提供更清晰的「總醫療成本」會計來應對這項挑戰。關稅環境也促使企業投資於本地組裝和測試能力，這可以減輕進口關稅的影響，並縮短產品迭代的監管申報時間。最後，支付方和醫療系統正在密切關注這些動態，並日益將報銷討論與可證明的價值和長期成本抵消聯繫起來，而不僅僅是考慮產品的領先價格。

提供可操作的細分洞察，揭示產品架構、臨床環境和通路如何影響競爭定位和市場接受度動態。

細分市場層面的動態變化揭示了產品類型、終端用戶和通路之間的有效差異化，直接影響產品開發重點和商業規劃。就產品類型而言，內視鏡縫合器材正在不斷發展，競爭的縫合系統和成熟的平台（如Overstitch）優先考慮更小的輸送尺寸和更高的組織縫合一致性。射頻消融器械的定位則取決於先進的導管系統，後者強調病灶控制和能量調節，而標準導管系統則強調成本和易用性。在外科腹腔鏡成形術領域，傳統的腹腔鏡系統正被機器人輔助腹腔鏡系統所取代，後者提供了更高的靈活性和更清晰的視野。經口、無切口腹腔鏡成形術平台（例如Esophyx系統和新一代腹腔鏡成形術解決方案）的競爭主要體現在手術時間、解剖修復的持久性和門診病人的可及性。

終端用戶細分進一步細化了購買行為和臨床路徑。門診手術中心（包括獨立中心和醫院附屬中心）傾向於選擇支持短期住院或當日出院通訊協定並最大限度減少資本投入的設備。診所，包括基層醫療和專科醫院，傾向於在手術量和訓練能力之間取得平衡，而專科胃腸病中心和多學科中心則優先考慮不同的手術組合和術後支持模式。分銷管道細分錶明，直銷仍然是高觸感設備推廣的首選途徑，而透過電子商務平台和製造商入口網站進行的線上銷售在耗材和輔助工具方面正在成長，全國性和區域性第三方分銷商在擴大產品覆蓋範圍至各種臨床環境方面繼續發揮關鍵作用。綜上所述，這些細分洞察表明，製造商必須根據每個使用者群體獨特的經濟和業務限制來調整其產品功能、培訓計劃和通路策略。

關鍵區域洞察，闡述美洲、歐洲、中東和非洲以及亞太地區的市場動態將如何影響監管、臨床和供應鏈策略。

區域動態對美洲、歐洲、中東和非洲以及亞太市場的監管路徑、臨床應用模式和供應鏈韌性有顯著影響。在美洲，強大的醫院網路和日益增多的門診手術中心傾向於選擇具有已證實的門診療效和可靠臨床證據的醫療設備，而採購週期和支付方談判則更側重於降低整體醫療成本。該地區也是下一代系統早期商業化推出的中心，其臨床效用由臨床專家和學術中心檢驗。

在中東和非洲，監管體系的多樣性和報銷框架的碎片化意味著打入市場策略必須根據各國的具體臨床指南和採購慣例量身定做。專科中心，尤其是那些專注於微創手術的中心，可以透過制定符合衛生經濟學評估和真實世界證據的價值檔案來加速市場進入。在亞太地區，醫療基礎設施的快速投資以及訓練有素的內視鏡醫師和外科醫生隊伍的不斷壯大，推動了人們對具成本效益技術和可擴展培訓模式的興趣。此外，該地區的製造和組裝中心是尋求供應鏈多元化和降低進口關稅影響的企業的重要戰略支柱，而本地臨床試驗以及與區域意見領袖的夥伴關係可以顯著促進技術的推廣應用。

決定胃食道逆流（GERD）器材市場競爭優勢的關鍵公司層級因素包括平台策略、夥伴關係、臨床證據和售後服務。

胃食道逆流症醫療器材市場的競爭格局受到多方因素的影響，包括成熟的醫療設備製造商、專注於平台擴充性和臨床整合的專業新興企業以及跨學科技術合作夥伴。大型公司正投資於模組化平台策略，以實現功能增量升級而無需徹底改造硬體，從而縮短產品迭代周期並減輕監管負擔。同時，規模較小的創新者正透過解決特定的臨床痛點，例如縮小設備體積、簡化部署流程和改善術後監測，來開闢利基市場。

為了將臨床信譽與商業規模相結合，企業普遍採取策略聯盟和選擇性收購的方式，而售後服務（例如，手術培訓、指導和一次性耗材項目）作為收入和客戶維係手段的重要性也日益凸顯。智慧財產權組合和臨床證據的深度是影響醫院處方決策和支付方談判的關鍵差異化因素。最後，整合了數位健康功能、患者報告結果追蹤和遠端追蹤工具的企業更有可能與尋求綜合護理路徑而非獨立設備的醫療系統簽訂長期合約。

為領導者提供有針對性的實用建議，以加強供應鏈、證據收集、培訓計劃和商業模式，從而加速產品推廣並確保獲利。

產業領導者應優先採取一系列切實可行、注重執行的措施，以應對當前的挑戰並抓住新的機會。首先，應考慮實現零件採購多元化，並將關鍵子次組件流程外包至近岸地區，以降低關稅風險並減少前置作業時間波動。在增強供應鏈韌性的同時，應投資以產生符合支付方終點和醫院價值框架的臨床證據，並專注於耐用性、生活品質和成本抵消分析，以支持門診和醫院的推廣應用。

第二，我們將設計培訓和指導項目，以降低學習曲線，實現快速規模化，並擴展在門診手術中心和專科診所的應用場景。第三，我們將採用靈活的商業模式，結合電子商務和經銷商獎勵銷售耗材和配件，並輔以直銷以實現高高觸感率，同時協商捆綁定價和訂閱模式，使激勵機制與長期成果保持一致。第四，我們將加速開發下一代設備功能，例如核磁共振安全材料、可調式磁性結構和先進的導管控制技術，以使我們的產品藍圖脫穎而出。第五，我們將積極與監管機構和支付方溝通，簡化醫保覆蓋流程，並推動其納入臨床指南。最後，我們將針對價格調整和報銷政策變化進行情境規劃，以確保定價的靈活性，並持續投入研發和臨床醫生參與。

透明嚴謹的調查方法，結合了一手資料和二手資料研究。調查方法融合了與臨床醫生和採購負責人的訪談、二手臨床和監管研究以及供應鏈分析。

本分析的調查方法結合了結構化的初步研究、嚴謹的二次綜合分析和迭代檢驗，以確保其可靠性和實用性。初步研究包括對臨床醫生、採購負責人、供應鏈經理和行業高管進行結構化訪談，以了解設備在實際應用中的表現、推廣障礙和採購偏好。二次研究包括對同行評審的臨床文獻、監管文件、手術編碼指南和公開的技術摘要進行系統性回顧，以梳理設備功能集和臨床終點。

透過將訪談內容與監管文件和製造商的技術規範進行交叉比對，實現了資料三角驗證。供應鏈圖譜利用貿易流量、零件採購模式和生產佈局分析，解讀了關稅和物流限制的影響。品管包括臨床專家和方法學家的同行評審、分歧的協調以及假設的透明記錄。鑑於存在區域數據缺口或長期耐久性證據尚不成熟等局限性，該報告建議隨著更多真實世界證據的出現和監管決策的製定，定期更新報告。

結論的全面總結強調了將臨床證據、供應鏈韌性和適應性商業化相結合，以引領胃食道逆流（GERD）器材的普及應用至關重要。

摘要，受技術進步、門診治療模式轉變以及支付方期望變化等因素驅動，胃食道逆流症器械市場正處於曲折點。那些能夠平衡產品研發與臨床價值驗證、投資完善的培訓和售後服務項目並建立穩健供應鏈的開發商，將更有利於充分利用微創、以門診病人為主的治療路徑轉變帶來的機會。關稅環境的累積和區域監管差異雖然增加了市場的複雜性，但也為企業回流和建立策略夥伴關係關係創造了獎勵，從而帶來競爭優勢。

最終，成功與否取決於能否將臨床前景轉化為可複製的成果，能否向支付方和醫療服務提供方清晰地闡明價值提案，以及能否實施一種適應性強的商業模式，以反映門診手術中心、診所和醫院的運作方式。相關人員，將引領下一波技術應用浪潮，並塑造長期的醫療服務標準。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 使用磁性括約肌增強裝置取代長期PPI治療
  • 透過將即時電阻pH監測導管與無線數據分析結合，實現個人化逆流管理
  • 開發一種經口無切口胃底折疊術系統，並增強其內視鏡縫合功能
  • 推廣可生物分解支架技術，以最大程度減少難治性胃食道逆流症患者的併發症
  • 遠端患者監護平台對胃底折疊術後胃食道逆流症治療長期療效的影響
  • 利用新型超音波導引球囊系統進行酸袋標靶治療的療效
  • 以患者為中心的數位健康應用程式在症狀追蹤和人工智慧驅動的治療建議方面取得了成長

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 胃食道逆流症治療設備市場（依產品類型分類）

  • 內視鏡縫合器械
    • 競爭性縫合系統
    • 包縫系統
  • 磁性括約肌增強裝置
    • 第一代系統
    • 下一代系統
  • 射頻消融術裝置
    • 高階導管系統
    • 標準導管系統
  • 外科胃底折疊裝置
    • 傳統腹腔鏡系統
    • 機器人輔助腹腔鏡系統
  • 經口無切口胃底折疊裝置
    • Ethofix Systems
    • 下一代胃底折疊術系統

9. 依最終用戶分類的胃食道逆流症治療設備市場

  • 門診手術中心
    • 獨立中心
    • 醫院相關中心
  • 診所
    • 基層醫療診所
    • 專科診所
  • 醫院
    • 綜合醫院
    • 專業中心
      • 消化系統專科中心
      • 多專科中心

第10章 胃食道逆流症治療器材市場（依分銷管道分類）

  • 直銷
  • 線上銷售
    • 電子商務平台
    • 製造商門戶
  • 第三方經銷商
    • 全國經銷商
    • 區域經銷商

第11章 各地區胃食道逆流症治療器材市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 胃食道逆流症治療器材市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國胃食道逆流症治療器材市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Johnson & Johnson
    • Medtronic plc
    • Boston Scientific Corporation
    • Olympus Corporation
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • Torax Medical, Inc.
    • Mederi Therapeutics, Inc.
    • EndoGastric Solutions, Inc.
    • GI Dynamics, Inc.
Product Code: MRR-925E8149CEF2

The Gastroesophageal Reflux Disease Devices Market is projected to grow by USD 19.04 billion at a CAGR of 14.05% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.65 billion
Estimated Year [2025] USD 7.58 billion
Forecast Year [2032] USD 19.04 billion
CAGR (%) 14.05%

A comprehensive introduction to the evolving gastroesophageal reflux disease device landscape and the clinical and commercial forces driving rapid innovation

Gastroesophageal reflux disease remains a clinically significant condition that continues to shape procedural innovation and device development across endoscopic, magnetic, radiofrequency, and surgical approaches. Clinicians and health systems are increasingly seeking interventions that reduce long-term medication dependence, minimize perioperative risk, and enable same-day pathways. As a result, the device landscape is characterized by rapid iteration, a heightened focus on patient-centric outcomes, and the emergence of outpatient-optimized technologies.

In parallel, payer scrutiny and hospital procurement cycles are shaping adoption curves, while clinical evidence requirements for safety and durability are becoming more rigorous. Transitioning care away from inpatient admissions toward ambulatory surgical centers and specialized clinics is exerting pressure on device manufacturers to deliver compact, cost-effective, and interoperable systems that integrate with existing operating room technology stacks. Consequently, commercial and clinical leaders must navigate an environment where technological promise must be matched by reproducible clinical performance and viable reimbursement strategies.

An in-depth look at the transformative clinical, technological, and commercial shifts reshaping GERD device adoption and provider decision-making

The landscape for gastroesophageal reflux disease devices is undergoing transformative shifts driven by procedural migration to minimally invasive platforms, the maturation of magnetic sphincter augmentation concepts, and the refinement of transoral and endoscopic suturing techniques. Clinicians are adopting approaches that seek to balance symptom control with anatomical preservation, and device developers are responding with iterations that prioritize ease of deployment, reproducibility, and reduced periprocedural morbidity.

Moreover, surgical fundoplication is evolving through greater use of robotic assistance and enhanced imaging, while radiofrequency ablation systems are differentiating on catheter design and energy delivery precision. These technology advances are occurring alongside broader healthcare system trends such as outpatient care expansion, value-based contracting, and greater emphasis on health economics. Consequently, market participants are compelled to align clinical evidence generation with user training programs and to redesign commercial models to support diverse end users, including freestanding ambulatory centers, hospital-affiliated facilities, and specialty clinics. This period of transformation therefore favors organizations that couple engineering agility with robust clinical validation and adaptive go-to-market strategies.

A strategic analysis of how the cumulative United States tariffs introduced in 2025 are restructuring supply chains, procurement behaviors, and device commercialization strategies

The cumulative effects of new United States tariffs enacted in 2025 are reshaping supply chain strategies, component sourcing decisions, and pricing dynamics across the gastroesophageal reflux disease device ecosystem. Device manufacturers that rely on imported specialty components such as precision catheters, magnetic materials, or microelectronics are experiencing higher landed costs, prompting reassessment of bill-of-materials optimization and accelerated evaluation of domestic or nearshore suppliers. As a result, procurement teams are prioritizing dual-sourcing, longer-term supplier agreements, and increased inventory buffers to mitigate cost volatility and lead-time uncertainty.

In addition, tariff-driven cost pressures are influencing go-to-market choices, with some manufacturers electing to absorb incremental costs to preserve competitive pricing while others are introducing differentiated service bundles to maintain margin. Hospitals and ambulatory surgical centers are responding by intensifying capital allocation reviews and demanding clearer total-cost-of-care narratives from device vendors. The tariff environment is also catalyzing investment in localized assembly and testing capabilities, which reduces exposure to import duties and can shorten regulatory submission timelines for incremental device iterations. Finally, payers and health systems are watching these developments closely, increasingly tying reimbursement conversations to demonstrable value and long-term cost offsets rather than upfront device price alone.

Actionable segmentation insights revealing how product architectures, clinical settings, and distribution pathways influence competitive positioning and adoption dynamics

Segment-level dynamics reveal meaningful differentiation across product types, end users, and distribution avenues that directly inform product development priorities and commercial planning. Within product type segmentation, endoscopic suturing devices are evolving with competitive suturing systems and established Overstitch-like platforms prioritizing smaller-profile delivery and improved tissue apposition consistency, while magnetic sphincter augmentation offerings continue to advance from first generation designs toward next generation systems that focus on adjustability, MRI compatibility, and simplified implantation workflows. Radiofrequency ablation devices are being positioned through advanced catheter systems that emphasize lesion control and energy modulation versus standard catheter systems where cost and ease of use remain dominant considerations. In the surgical fundoplication space, conventional laparoscopic systems are increasingly complemented by robotic assisted laparoscopic systems that offer enhanced dexterity and visualization but require different capital and training commitments. Transoral incisionless fundoplication platforms, represented by entrenched Esophyx-like systems and emergent next generation fundoplication solutions, are competing on procedure time, durability of anatomical repair, and outpatient readiness.

End user segmentation further nuances purchasing behavior and clinical pathways. Ambulatory surgical centers, including both freestanding centers and hospital-affiliated centers, are gravitating toward devices that support short-stay or same-day discharge protocols and that minimize capital footprint. Clinics, whether primary care clinics or specialty clinics, are more selective in device adoption, often focusing on referral networks and diagnostic-to-procedure continuity. Hospitals, including general hospitals and specialty centers, tend to balance surgical volume considerations against training capacity, with gastroenterology specialty centers and multispecialty centers each prioritizing different procedural mixes and post-procedure support models. Distribution channel segmentation highlights that direct sales remain the preferred route for high-touch device adoption, whereas online sales through e-commerce platforms and manufacturer portals are growing for consumables and adjunct tools, and third party distributors, both national and regional, continue to play an essential role in extending reach into varied clinical settings. Collectively, these segmentation insights underscore the need for manufacturers to tailor product feature sets, training programs, and channel strategies to the specific economics and operational constraints of each buyer cohort.

Critical regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific market dynamics shape regulatory, clinical, and supply chain strategies

Regional dynamics materially influence regulatory pathways, clinical adoption patterns, and supply chain resilience across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. In the Americas, strong hospital networks and growing ambulatory surgical center capacity favor devices that demonstrate outpatient efficacy and robust clinical evidence, while procurement cycles and payer negotiations place emphasis on demonstrable reductions in total cost of care. This region also serves as a focal point for early commercial launches of next generation systems, where clinician champions and academic centers validate clinical utility.

In Europe Middle East & Africa, regulatory heterogeneity and fragmented reimbursement frameworks mean that market entry strategies must be tailored to country-specific clinical guidelines and procurement practices. Here, value dossiers that address health economic evaluations and real-world evidence can accelerate uptake, particularly in specialty centers that emphasize minimally invasive care. In the Asia-Pacific region, rapid investment in healthcare infrastructure and an expanding base of trained endoscopists and surgeons are driving interest in cost-efficient technologies and scalable training models. Manufacturing and assembly footprints in this region also act as strategic anchors for companies seeking to diversify supply chains and reduce exposure to import tariffs, while local clinical studies and partnerships with regional opinion leaders can meaningfully influence adoption.

Key company-level insights highlighting how platform strategies, partnerships, clinical evidence, and aftermarket services determine competitive advantage in the GERD devices market

Competitive dynamics in the gastroesophageal reflux disease device arena are influenced by a mix of established medical device organizations, specialized emerging firms, and cross-sector technology partners focused on platform scalability and clinical integration. Leading players are investing in modular platform strategies that enable incremental feature upgrades without wholesale reinvention of hardware, thereby shortening product iteration cycles while managing regulatory burden. Concurrently, smaller innovators are carving niche positions by solving specific clinical pain points such as device profile reduction, simplified deployment, or improved post-procedure monitoring.

Strategic partnerships and selective acquisitions are common as companies seek to combine clinical credibility with commercialization scale, and aftermarket services-such as procedural training, proctoring, and disposable consumable programs-are increasingly important revenue and retention levers. Intellectual property portfolios and the depth of clinical evidence are crucial differentiators that influence hospital formulary decisions and payer discussions. Finally, companies that integrate digital health capabilities, patient-reported outcome tracking, and remote follow-up tools are more likely to secure long-term contracts with health systems seeking comprehensive care pathways rather than standalone devices.

Targeted and practical recommendations for leaders to fortify supply chains, evidence generation, training programs, and commercial models to accelerate adoption and protect margin

Industry leaders should prioritize a set of practical, execution-focused actions to navigate current headwinds and capture emerging opportunities. First, diversify component sourcing and consider nearshoring critical subassembly processes to mitigate tariff exposure and reduce lead-time variability. Parallel to supply chain resilience, invest in clinical evidence generation that aligns with payer endpoints and hospital value frameworks, focusing on durability, quality-of-life measures, and cost-offset analyses that support adoption across ambulatory and hospital settings.

Second, design training and proctoring programs that lower the procedural learning curve and enable rapid scale within ambulatory surgical centers and specialty clinics, thereby expanding addressable use cases. Third, adopt flexible commercial models that combine direct sales for high-touch conversions with expanded e-commerce and distributor partnerships for consumables and adjuncts, while negotiating bundled pricing or subscription approaches that align incentives with long-term outcomes. Fourth, accelerate development of next generation device features such as MRI-safe materials, adjustable magnetic constructs, and advanced catheter control to differentiate product roadmaps. Fifth, engage proactively with regulators and payers to streamline coverage pathways and to influence clinical guideline inclusion. Finally, implement scenario planning for tariff shifts and reimbursement changes to ensure pricing agility and to preserve investments in R&D and clinician engagement.

A transparent and rigorous research methodology combining primary clinician and procurement interviews with secondary clinical and regulatory synthesis and supply chain mapping

The research methodology underpinning this analysis combines structured primary inquiry with rigorous secondary synthesis and iterative validation to ensure credibility and actionable relevance. Primary research involved structured interviews with clinicians, procurement leaders, supply chain managers, and industry executives to capture real-world device performance, adoption barriers, and procurement preferences. Secondary research included systematic review of peer-reviewed clinical literature, regulatory filings, procedure coding guidelines, and publicly available technology briefs to map device feature sets and clinical endpoints.

Data triangulation was applied by cross-referencing interview insights with regulatory documentation and manufacturer technical specifications. Supply chain mapping leveraged trade flows, component sourcing patterns, and manufacturing footprint analyses to interpret tariff impacts and logistical constraints. Quality control measures included peer review by clinical experts and methodologists, reconciliation of divergent viewpoints, and transparent documentation of assumptions. Limitations are acknowledged where regional data gaps exist or where long-term durability evidence is still maturing, and the report recommends periodic updates as additional real-world evidence and regulatory decisions become available.

Concluding synthesis emphasizing the imperative to align clinical evidence, supply chain resilience, and adaptive commercialization to lead in GERD device adoption

In summary, the gastroesophageal reflux disease device market is at an inflection point driven by technological refinement, procedural migration to ambulatory settings, and evolving payer expectations. Manufacturers that align product development with demonstrable clinical value, invest in robust training and aftercare programs, and build resilient supply chains will be best positioned to capitalize on the shift toward minimally invasive and outpatient-centric care pathways. The cumulative tariff environment and regional regulatory heterogeneity add complexity, but they also create incentives for onshoring and strategic partnerships that can yield competitive advantage.

Ultimately, success will hinge on the ability to translate clinical promise into reproducible outcomes, to present clear value propositions to payers and providers, and to execute adaptable commercial models that reflect the operational realities of ambulatory surgical centers, clinics, and hospitals. Stakeholders who combine clinical rigor, supply chain foresight, and customer-centric commercialization will lead the next wave of adoption and shape long-term standards of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of magnetic sphincter augmentation devices as an alternative to long-term PPI therapy
  • 5.2. Integration of real-time impedance-pH monitoring catheters with wireless data analytics for personalized reflux management
  • 5.3. Development of transoral incisionless fundoplication systems with enhanced endoscopic suturing capabilities
  • 5.4. Expansion of biodegradable stent technologies to minimize complications in refractory GERD patients
  • 5.5. Impact of remote patient monitoring platforms on long-term outcomes in post-fundoplication GERD treatment
  • 5.6. Efficacy of emerging acid pocket targeting technologies using novel ultrasound-guided balloon systems
  • 5.7. Growth of patient-centric digital health applications for symptom tracking and AI-driven treatment recommendations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroesophageal Reflux Disease Devices Market, by Product Type

  • 8.1. Endoscopic Suturing Devices
    • 8.1.1. Competitor Suturing Systems
    • 8.1.2. Overstitch Systems
  • 8.2. Magnetic Sphincter Augmentation Devices
    • 8.2.1. First Generation Systems
    • 8.2.2. Next Generation Systems
  • 8.3. Radiofrequency Ablation Devices
    • 8.3.1. Advanced Catheter Systems
    • 8.3.2. Standard Catheter Systems
  • 8.4. Surgical Fundoplication Devices
    • 8.4.1. Conventional Laparoscopic Systems
    • 8.4.2. Robotic Assisted Laparoscopic Systems
  • 8.5. Transoral Incisionless Fundoplication Devices
    • 8.5.1. Esophyx Systems
    • 8.5.2. Next Generation Fundoplication Systems

9. Gastroesophageal Reflux Disease Devices Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Freestanding Centers
    • 9.1.2. Hospital Affiliated Centers
  • 9.2. Clinics
    • 9.2.1. Primary Care Clinics
    • 9.2.2. Specialty Clinics
  • 9.3. Hospitals
    • 9.3.1. General Hospitals
    • 9.3.2. Specialty Centers
      • 9.3.2.1. Gastroenterology Specialty Centers
      • 9.3.2.2. Multispecialty Centers

10. Gastroesophageal Reflux Disease Devices Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Online Sales
    • 10.2.1. E Commerce Platforms
    • 10.2.2. Manufacturer Portals
  • 10.3. Third Party Distributors
    • 10.3.1. National Distributors
    • 10.3.2. Regional Distributors

11. Gastroesophageal Reflux Disease Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Gastroesophageal Reflux Disease Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Gastroesophageal Reflux Disease Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Johnson & Johnson
    • 14.3.2. Medtronic plc
    • 14.3.3. Boston Scientific Corporation
    • 14.3.4. Olympus Corporation
    • 14.3.5. Becton, Dickinson and Company
    • 14.3.6. Cook Medical LLC
    • 14.3.7. Torax Medical, Inc.
    • 14.3.8. Mederi Therapeutics, Inc.
    • 14.3.9. EndoGastric Solutions, Inc.
    • 14.3.10. GI Dynamics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COMPETITOR SUTURING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OVERSTITCH SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FIRST GENERATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ADVANCED CATHETER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STANDARD CATHETER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CONVENTIONAL LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NEXT GENERATION FUNDOPLICATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRIMARY CARE CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GASTROENTEROLOGY SPECIALTY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MULTISPECIALTY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANUFACTURER PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES M